Moreover, the deletion of STING in tumor cells markedly reversed the dMMR-mediated reduction in tumor growth, as well as the elevated levels of CXCL10 expression and increased recruitment of CD8+ T cells in the TME 28. This evidence concerns the gene STING1 and neoplasm.